最新的帖子

一月 06, 2021

West Presented on China Registrations for Combination Products at Annual ISPE Meeting & Expo

On <span>November 6, 2020</span>, West&rsquo;s Regulatory Affairs Senior Director, Lynn Lundy, presented at the 2020 ISPE (International Society for Pharmaceutical Engineering) Annual Meeting and Expo. The week-long virtual meeting focused on steering the future of pharmaceutical science and manufacturing toward a more global, synchronized, and quality-driven industry. Pharmaceutical and biopharmaceutical professionals from drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies were in attendance to discuss hot topics such as Data Integrity, Covid-19 Impact, Combination Products and more.

Katie Casale

Associate Specialist, Regulatory Affairs

以前的博客

十二月 17, 2020

Guideline for Nitrosamine Impurities in China

Candice Sun

Candice Sun

Specialist, Scientific Affairs, CN

Stoppers

十一月 20, 2020

New USP Chapters <381>, <382>, <1381>, and <1382>

Daniel Bantz

Daniel Bantz

Manager, Scientific Communications, Self Injection Systems

Bettine Boltres presents at PDA Webinar

八月 24, 2020

How to Include Elastomers in the Nitrosamine Risk Assessment

Bettine Boltres

Dr. Bettine Boltres

Principal Scientific Affairs, Packaging & Delivery Systems

Load more